Text Size

a A

Menu

Home > Newsroom > Publications > A Decade After Ariad: What Is the Written Description Standard for Emerging BioPharma Patents?

A Decade After Ariad: What Is the Written Description Standard for Emerging BioPharma Patents?

Washington Journal of Law, Technology & Arts, Vol. 17 Issue 1

February 22, 2022

Pu-Cheng (Leo) Huang

< Return to Publications